A carregar...
Therapeutic Updates for Relapsed and Refractory Classical Hodgkin Lymphoma
SIMPLE SUMMARY: The approach to relapsed and refractory classical Hodgkin lymphoma is rapidly evolving. Over the past five years, we have seen the arrival of novel immunotherapies with impressive clinical response rates. These agents are actively being investigated earlier in the sequence of therapi...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7601361/ https://ncbi.nlm.nih.gov/pubmed/33050054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102887 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|